ABSI
Absci Corporation
There isn't enough reported data to score ABSI yet.
ABSI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Weak | |
| Unavailable |
ABSI's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
ABSI PE Valuation
ABSI has no meaningful PE right now: it lost money over the past year.
ABSI Forward outlook
There aren't enough analyst estimates for ABSI to show an outlook.
ABSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.78 | +$0.13 |
| Q2 2026 | -$0.79 | +$0.16 |
| Q1 2026 | -$0.82 | +$0.11 |
| Q4 2025 | -$0.84 | +$0.10 |
| Q3 2025 | -$0.91 | +$0.02 |
| Q2 2025 | -$0.95 | -$0.02 |
| Q1 2025 | -$0.93 | +$0.23 |
| Q4 2024 | -$0.94 | +$0.26 |
ABSI is still losing money, but far less than before: $0.78 per share over the past year, against $2.89 at its worst in late 2021.
ABSI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $304K | -20% |
| Q2 2026 | $318K | -46% |
| Q1 2026 | $215K | -82% |
| Q4 2025 | $650K | -2.3% |
| Q3 2025 | $378K | -78% |
| Q2 2025 | $593K | -53% |
| Q1 2025 | $1.2M | +31% |
| Q4 2024 | $665K | +97% |
ABSI's revenue has slid since its 2023 peak: $304,000 last quarter, down 20% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -11511% | -3534 points |
| Q2 2026 | -10742% | -5448 points |
| Q1 2026 | -14347% | -11995 points |
| Q4 2025 | -4776% | -298 points |
| Q3 2025 | -7977% | -6279 points |
| Q2 2025 | -5294% | -3190 points |
| Q1 2025 | -2352% | +265 points |
| Q4 2024 | -4477% | +2842 points |
ABSI's operating margin was −11511% last quarter, down 3534 points from the same quarter a year ago, near the bottom of its range since 2020.
ABSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$29.5M | -$3.5M |
| Q2 2026 | -$27.6M | -$10.5M |
| Q1 2026 | -$26.3M | -$4.5M |
| Q4 2025 | -$29.1M | -$12.1M |
| Q3 2025 | -$26M | -$5.2M |
| Q2 2025 | -$17.1M | +$80K |
| Q1 2025 | -$21.9M | -$4M |
| Q4 2024 | -$17M | -$2M |
ABSI has burned cash in almost every quarter: −$112M over the past year, against −$82M the year before.
ABSI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +14.3M shares |
| 1 year | +19% | +28M shares |
| 3 years | +86% | +79.6M shares |
| 5 years | +874% | +154M shares |
| Available history | +90% | +81.4M shares |
ABSI has 172M diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
ABSI Net Leverage
ABSI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ABSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.8 | Neutral |
| Stochastic | 52.6 | Neutral |
ABSI's weekly RSI is 53 (neutral) and its Stochastic is 53 (neutral).
ABSI PE vs Healthcare Sector
ABSI has no meaningful PE right now: it lost money over the past year.
ABSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $9.85 | 7.3% below |
| 20 week MA | $9.39 | 2.8% below |
| 50 week MA | $6.24 | 46% above |
| 100 week MA | $4.70 | 94% above |
| 200 week MA | $3.87 | 136% above |
ABSI has pulled back, but its long-term trend is still up: it's below its 8- and 20-week averages, but 136% above its 200-week average.
ABSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $22.9 | $8.67 | -62% |
| 2022 | $8.67 | $2.17 | -75% |
| 2023 | $2.17 | $4.20 | +94% |
| 2024 | $4.20 | $2.77 | -34% |
| 2025 | $2.77 | $3.57 | +29% |
| 2026 YTD | $3.57 | $9.13 | +156% |
ABSI is up 156% so far in 2026, after finishing lower in three of the previous five years.